Ritonavir Market: The Future of Digital Transformation Ritonavir Market size is estimated to be USD 1.2 Billion in 2024 and is expected to reach USD 2.5 Billion by 2033 at a CAGR of 9.2% from 2026 to 2033. Ritonavir Market Future Scope The global Ritonavir market size was valued at approximately USD 350 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.4% from 2022 to 2030. The increasing prevalence of HIV/AIDS, combined with the rise in antiretroviral therapy adoption, is anticipated to fuel the demand for Ritonavir during the forecast period. Moreover, the drug’s role as a key protease inhibitor in combination therapies to treat HIV infection is expected to drive its continued market growth. As Ritonavir is also used in combination with other drugs to manage HIV/AIDS, its market is witnessing steady growth across both developed and emerging economies. The global shift towards more comprehensive treatment regimens is one of the major contributors to its steady demand in the healthcare sector. The future scope of the Ritonavir market appears promising, with a projected market value of USD 550 million by 2030. The growth is expected to be driven by increasing […]